Amgen Inc
AMGNNasdaqCIK 318154HealthcareFiscal year ends Dec 31
Reports and events: 319 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2717:58 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000318154-26-000144 |
| 2026-08-0518:29 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000318154-26-000126 |
| 2026-08-0416:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-26-000124 |
| 2026-07-3116:03 ET | 8-K | 1.05 Material cybersecurity incident | 0000318154-26-000119 |
| 2026-05-2016:59 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-232786 |
| 2026-05-1916:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000318154-26-000097 |
| 2026-05-0119:04 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000318154-26-000057 |
| 2026-04-3016:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-26-000054 |
| 2026-04-2216:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000318154-26-000048 |
| 2026-04-0716:22 ET | DEF 14A | Proxy statementPeriod 2026-05-19 | 0001193125-26-145588 |
| 2026-02-1916:27 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-059490 |
| 2026-02-1316:07 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000318154-26-000010 |
| 2026-02-0316:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-26-000003 |
| 2026-01-3008:00 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-030518 |
| 2025-11-0518:59 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000318154-25-000072 |
| 2025-11-0416:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-25-000070 |
| 2025-08-0619:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000318154-25-000056 |
| 2025-08-0516:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-25-000054 |
| 2025-05-2718:55 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-077233 |
| 2025-05-0218:54 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000318154-25-000020 |
| 2025-05-0116:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-25-000018 |
| 2025-04-0908:30 ET | DEF 14A | Proxy statementPeriod 2025-05-23 | 0000950170-25-052315 |
| 2025-02-1416:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000318154-25-000010 |
| 2025-02-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-25-000005 |
| 2024-10-3118:43 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000318154-24-000044 |
| 2024-10-3016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-24-000042 |
| 2024-08-0718:54 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000318154-24-000035 |
| 2024-08-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-24-000033 |
| 2024-06-0317:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-153221 |
| 2024-05-0319:27 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000318154-24-000020 |
| 2024-05-0216:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-24-000018 |
| 2024-04-1716:02 ET | DEF 14A | Proxy statementPeriod 2024-05-31 | 0001193125-24-099062 |
| 2024-02-1416:23 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000318154-24-000011 |
| 2024-02-0616:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-24-000004 |
| 2023-12-1409:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-295027 |
| 2023-10-3116:21 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000318154-23-000064 |
| 2023-10-3107:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-23-000061 |
| 2023-10-0616:01 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-252361 |
| 2023-10-0507:43 ET | 8-K | 8.01 Other events | 0001193125-23-251090 |
| 2023-09-2707:30 ET | SC 13D | Ownership report, active investor | 0001193125-23-243053 |
| 2023-09-1207:30 ET | 8-K | 8.01 Other events | 0001193125-23-233011 |
| 2023-09-0509:12 ET | 8-K | 8.01 Other events | 0001193125-23-228161 |
| 2023-09-0109:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-227040 |
| 2023-08-0419:28 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000318154-23-000053 |
| 2023-08-0417:48 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-203033 |
| 2023-08-0316:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-23-000049 |
| 2023-06-0508:00 ET | 8-K | 8.01 Other events | 0001193125-23-160316 |
| 2023-05-2217:23 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-150659 |
| 2023-05-1808:29 ET | 8-K | 8.01 Other events | 0001193125-23-147662 |
| 2023-05-1617:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-146219 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 19:36 ET. Listed shows no prices and gives no investment advice.